| Product Code: ETC7549565 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India open angle glaucoma market import shipment demonstrated robust growth with a high CAGR from 2020-2024. However, there was a slight decline in growth rate between 2023-2024. Overall, the market expanded significantly but showed signs of stabilizing towards the end of the period.
The India Open Angle Glaucoma market is characterized by a significant prevalence of the disease due to factors such as an aging population, increasing incidence of diabetes, and genetic predisposition. The market is driven by a growing awareness of the condition among patients and healthcare professionals, leading to early diagnosis and treatment initiation. Key players in the market offer a range of medications, surgical procedures, and devices for managing open-angle glaucoma. The market is witnessing technological advancements in diagnostic tools and treatment options, providing patients with more effective and minimally invasive solutions. Government initiatives to improve access to healthcare services and rising healthcare expenditure are further boosting market growth. However, challenges such as limited awareness in rural areas and affordability issues for certain segments of the population remain areas of concern for market expansion.
The India Open Angle Glaucoma market is witnessing several key trends and opportunities. With an increasing aging population and rising prevalence of glaucoma in India, there is a growing demand for advanced diagnostics and treatments. Technological advancements in imaging devices and surgical procedures are driving innovation in the market. Telemedicine and remote monitoring solutions are also gaining traction, especially in rural areas where access to eye care services is limited. Furthermore, collaborations between healthcare providers and pharmaceutical companies are enabling the development of personalized treatment options. The market offers opportunities for companies to invest in research and development of novel therapies, expand their product portfolios, and establish strategic partnerships to capitalize on the growing demand for glaucoma management solutions in India.
In the India Open Angle Glaucoma market, several challenges are faced, including low awareness among the population about the disease, leading to late diagnosis and treatment. Limited access to healthcare facilities, especially in rural areas, further exacerbates the issue. Affordability is a significant concern, as glaucoma treatment often requires ongoing medication and regular monitoring, which can be costly for many patients. Additionally, there is a shortage of skilled ophthalmologists in India, resulting in long waiting times for appointments and treatments. The lack of standardized protocols for glaucoma management and inconsistent quality of care across different healthcare facilities also pose challenges in effectively managing the disease and preventing vision loss in patients.
The India Open Angle Glaucoma market is primarily driven by factors such as the increasing prevalence of glaucoma in the country due to an aging population, changing lifestyle habits, and a rise in chronic diseases like diabetes. Additionally, growing awareness about eye health, advancements in diagnostic technologies, and the availability of innovative treatment options are also fueling market growth. Government initiatives to provide affordable healthcare services and the expanding healthcare infrastructure further contribute to the demand for glaucoma treatment in India. Moreover, collaborations between pharmaceutical companies and research institutions for the development of novel therapies are expected to drive market expansion in the coming years.
The Indian government has implemented various policies to address the issue of glaucoma in the country. The government has included glaucoma treatment under the National Programme for Control of Blindness (NPCB) and has set up Vision Centres to provide comprehensive eye care services, including screening and treatment for glaucoma. Additionally, the government has taken steps to increase public awareness about glaucoma through campaigns and initiatives. Furthermore, the government has reduced import duties on medical equipment related to eye care, making treatment more affordable and accessible. Overall, the government`s policies aim to improve access to glaucoma treatment, raise awareness about the condition, and reduce the burden of glaucoma-related blindness in India.
The India Open Angle Glaucoma market is expected to witness steady growth in the coming years due to an increasing prevalence of glaucoma in the country`s aging population. Factors such as improved healthcare infrastructure, rising awareness about eye diseases, and advancements in treatment options are likely to drive market expansion. Additionally, the growing adoption of minimally invasive surgical procedures and the availability of innovative pharmaceuticals will contribute to market growth. However, challenges such as limited access to healthcare services in rural areas and the high cost of glaucoma treatments may hinder market progress. Overall, with ongoing efforts to enhance early detection and treatment of glaucoma, the India Open Angle Glaucoma market is poised for moderate growth in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Open Angle Glaucoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Open Angle Glaucoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Open Angle Glaucoma Market - Industry Life Cycle |
3.4 India Open Angle Glaucoma Market - Porter's Five Forces |
3.5 India Open Angle Glaucoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Open Angle Glaucoma Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Open Angle Glaucoma Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Open Angle Glaucoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Open Angle Glaucoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of open-angle glaucoma in India |
4.2.2 Growing awareness and early diagnosis initiatives |
4.2.3 Technological advancements in glaucoma treatment and management |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost of glaucoma treatment and medication |
4.3.3 Lack of skilled healthcare professionals specializing in glaucoma care |
5 India Open Angle Glaucoma Market Trends |
6 India Open Angle Glaucoma Market, By Types |
6.1 India Open Angle Glaucoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Open Angle Glaucoma Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Open Angle Glaucoma Market Revenues & Volume, By Closed Angle Glaucoma (CAG), 2021- 2031F |
6.1.4 India Open Angle Glaucoma Market Revenues & Volume, By Open Angle Glaucoma (OAG), 2021- 2031F |
6.1.5 India Open Angle Glaucoma Market Revenues & Volume, By Secondary Glaucoma, 2021- 2031F |
6.1.6 India Open Angle Glaucoma Market Revenues & Volume, By Congenital Glaucoma, 2021- 2031F |
6.1.7 India Open Angle Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Open Angle Glaucoma Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Open Angle Glaucoma Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.2.3 India Open Angle Glaucoma Market Revenues & Volume, By Prostaglandins, 2021- 2031F |
6.2.4 India Open Angle Glaucoma Market Revenues & Volume, By Alpha Adrenergic Agonist, 2021- 2031F |
6.2.5 India Open Angle Glaucoma Market Revenues & Volume, By Carbonic Anhydrase Inhibitors, 2021- 2031F |
6.2.6 India Open Angle Glaucoma Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.7 India Open Angle Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Open Angle Glaucoma Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Open Angle Glaucoma Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India Open Angle Glaucoma Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 India Open Angle Glaucoma Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 India Open Angle Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Open Angle Glaucoma Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Open Angle Glaucoma Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 India Open Angle Glaucoma Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 India Open Angle Glaucoma Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Open Angle Glaucoma Market Import-Export Trade Statistics |
7.1 India Open Angle Glaucoma Market Export to Major Countries |
7.2 India Open Angle Glaucoma Market Imports from Major Countries |
8 India Open Angle Glaucoma Market Key Performance Indicators |
8.1 Number of glaucoma screening programs conducted annually |
8.2 Percentage increase in early diagnosis rates of open-angle glaucoma |
8.3 Adoption rate of advanced glaucoma treatment technologies |
8.4 Number of glaucoma specialists per capita |
8.5 Patient adherence rate to prescribed glaucoma treatment regimens |
9 India Open Angle Glaucoma Market - Opportunity Assessment |
9.1 India Open Angle Glaucoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Open Angle Glaucoma Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Open Angle Glaucoma Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Open Angle Glaucoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Open Angle Glaucoma Market - Competitive Landscape |
10.1 India Open Angle Glaucoma Market Revenue Share, By Companies, 2024 |
10.2 India Open Angle Glaucoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |